Preliminary Program

The 18th Annual Review of DDW and Other Key GI & Liver Meetings is available in the following format:

View online Flipbook

Download/View PDF

Click here to register

8:00 am - 9:00 am Registration and Breakfast
Room:  Crown Foyer/Princess
9:00 am - 9:05 am Welcome and Opening Remarks
Room:  Crown
Speaker: Dr. Imran Rasul

 

Details

Imran Rasul, MD. HBSc., FRCP(C)
Gastroenterology and Therapeutic Endoscopy
Trillium Health Partners
Staff Gastroenterology - Credit Valley Hospital
Lecturer - University of Toronto
Director - WGTA Endoscopy
President - Ontario Association of Gastroenterology

Dr. Imran Rasul completed his undergraduate training at the University of Toronto in 1992. He went on to complete his Medical Degree, Internal Medicine and Gastroenterology training at the University of Toronto. Further training in Advanced Therapeutic Endoscopy was completed at University of Toronto. He has been practicing in Mississauga at the Credit Valley Hospital for the past seven years. Dr. Rasul has an interest in Advanced Endoscopy and is Chair of the Endoscopy Unit at Credit Valley Hospital.

9:05 am - 9:25 am Ulcerative Colitis
Room:  Crown
Speaker: Dr. Reena Khanna †
 denotes real or potential conflict of interest

 

Details

Reena Khanna, MD, MSc., FRCP(C)
Associate Professor of Medicine
Department of Medicine, Division of Gastroenterology
University of Western Ontario
London Ontario Canada

Dr. Reena Khanna is an Associate Professor of Medicine at the University of Western Ontario, and a Clinician Researcher in the Program for Experimental Medicine. She completed her MD and Internal Medicine residency at the University of Western Ontario, Gastroenterology fellowship at McMaster University.   Dr. Khanna completed an advanced fellowship in inflammatory bowel disease (IBD) at the Cleveland Clinic, followed by a research fellowship in international IBD clinical trials at the University of Western Ontario.   She completed an MSc in clinical epidemiology at McMaster University.  Her clinical and research interest are clinical trial design, new therapeutics, outcome measures.  She has designed, conducted and published several studies, including the first cluster study in IBD.  Dr. Khanna holds international grants and most recently was awarded the Crohn’s Colitis Canada’s rising star award for her research contributions.

9:25 am - 9:45 am Crohn's Disease
Room:  Crown
Speaker: Dr. Natasha Bollegala †
 denotes real or potential conflict of interest

 

Details

Natasha Bollegala, Hon BSc., MD, MSc., FRCP(C)
Staff Gastroenterologist, Women’s College Hospital
Assistant Professor, Faculty of Medicine, University of Toronto
Clinician Investigator in Quality & Innovation, University of Toronto

Dr. Natasha Bollegala HonBSc, MD, MSc, FRCPC is a staff gastroenterologist at Women’s College Hospital, Assistant Professor in the Department of Medicine, University of Toronto and Fellow in the Institute of Clinical Evaluative Sciences (ICES). She is a clinician investigator in quality and innovation, Department of Medicine, University of Toronto. She completed an Inflammatory Bowel Disease (IBD) fellowship at Mount Sinai Hospital, Toronto, an MSc in clinical epidemiology and healthcare research at UofT in 2016, the Eliot Phillipson Clinician Scientist Training Program and the Clinician Investigator Program at the University of Toronto.

Dr. Bollegala has an interest in the area of quality improvement and vulnerable populations in IBD. She conducts research related to IBD with a particular focus on pediatric to adult transition of care. She serves as the quality Improvement advisor to the colonoscopy - quality management partnership, CPSO. She co-chairs the Canadian IBD Transition Network. She leads the QI primer initiative with the quality affairs board of the Canadian Association of Gastroenterology and is on the Board of Directors for the Ontario Association of Gastroenterology. 

9:45 am - 10:05 am Top Four Cannabis Abstracts
Room:  Crown
Speaker: Dr. Colleen Parker †
 denotes real or potential conflict of interest

 

Details

Colleen Parker, MD, FRCP(C)
Clinical Associate
Division of Gastroenterology
University Health Network

Dr. Colleen Parker received her MD degree and completed her internal medicine and gastroenterology residencies at the University of Toronto.  She completed advanced training in the field of neurogastroenterology and motility at the Vatche and Tamar Manoukian Division of Digestive Diseases and the G. Oppenheimer Center for Neurobiology of Stress and Resilience at the University of California, Los Angeles.  Dr. Parker is currently a clinical associate in the Division of Gastroenterology at the University Health Network.  In addition, she is currently completing a Masters degree in the field of Clinical Epidemiology through the Institute of Health Policy, Management and Education at the University of Toronto.  

Presentation Overview:
The use of cannabis for both medical and recreational purposes is steadily increasing, particularly in light of its recent legalization in Canada.  The endocannabinoid modulates a variety of gastrointestinal functions.  Due to this, cannabis has the potential to be of therapeutic benefit for various gastrointestinal disorders yet there is concern that it may cause harm based on its association with hyperemesis.  The purpose of this presentation will be to review four abstracts from DDW 2019 that examine the potential role of cannabis as both a treatment and cause of gastrointestinal symptoms.

Abstracts to be presented:

  1. 26: The Effect of Recreational Marijuana Use on Bowel Function in a Nationwide Survey
  2. 108: The Prevalence and Use of Cannabis by Patients with Inflammatory Bowel Disease
  3. Mo1592: Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit
  4. 1001: Impact of Recreational Cannabis Legalization on Hospitalizations for Hyperemesis
10:05 am - 10:30 am MORNING DISCUSSION – PART I
Room:  Crown
Moderator: Dr. David Morgan †
 denotes real or potential conflict of interest

 

Details

David Morgan, MD, MSc., FRCP(C) 
Vice President, OAG
Head, Service of Gastroenterology
St. Joseph's Healthcare, Hamilton
Associate Professor, Division of Gastroenterology
McMaster University

Dr. David Morgan completed his undergraduate training in Human Genetics at McGill University. He did graduate studies including a Masters in Population Genetics. His undergraduate medical studies were completed at McMaster University and Post Graduate studies including Internal Medicine and Gastroenterology, were also completed at McMaster. Dr. Morgan took an additional fellowship year with special attention paid to advanced endoscopic techniques including YAG laser.

Dr. Morgan has published on topics such as GI Bleeding, Quality of Life in Cancer Care, Use of Proton Pump Inhibitors and The Prevention of Bleeding from GI Vascular Lesions. Dr. Morgan has participated on several CAG Consensus Panels dealing with such topics as CRC Screening. Dr. Morgan is a member of several international societies, is a Past President of the Canadian Association of Gastroenterology and is the current Vice President of the Ontario Association of Gastroenterology. Dr. Morgan is an Associate Editor for the ACP Journal Club and Evidence Based Medicine and has acted as a reviewer for many journals.

Dr. Morgan is on the Faculty at McMaster University and is involved in teaching at the undergraduate and post-graduate levels. He serves on many university and hospital committees. Dr. Morgan is Head of the Service of Gastroenterology and Deputy Chief of Medicine at St. Joseph's Hospital, Hamilton.

10:30 am - 11:00 am Coffee Break
Room:  Crown Foyer

11:00 am - 11:20 am

Functional GI Disorders
Room:  Crown
Speaker: Dr. Talia Zenlea †
 denotes real or potential conflict of interest

 

Details

Talia Zenlea, MD, FRCP(C)
GI, Women’s College Hospital
Assistant Professor, U of T
Associate Program Director, GI, U of T

Dr. Talia Zenlea received her medical degree from the University of Vermont in 2006. She completed her residency in internal Medicine at Yale University/Yale-New Haven Hospital, where she served as Chief Resident. She completed three years of subspecialty training in gastroenterology at Harvard University/Beth Israel Deaconess Medical Center, where she had a clinical focus in inflammatory bowel diseases. Thereafter, she joined the faculty at Brown University as an Assistant Professor of Medicine at Alpert Medical School, and acted as the Director of the Inflammatory Bowel Diseases Center at the Women’s Medicine Collaborative.

Dr. Zenlea joined the Division of Gastroenterology at Women's College Hospital in 2014 as an Assistant Professor of Medicine at the University of Toronto. She was appointed the Associate Program Director for the GI Training Program in 2018. She is otherwise a full time clinician, with a clinical interest in inflammatory bowel disease, particularly in pregnancy.

Presentation Overview:
This session will highlight the key developments in IBS presented at CDDW and DDW in 2019.

11:20 am - 11:40 am Acid-Related Disorders
Room:  Crown
Speaker: Dr. David Armstrong †
 denotes real or potential conflict of interest

 

Details

David Armstrong, MA, MB BChir, FRCP (UK), FRCP(C), FACG, AGAF
Professor, Division of Gastroenterology & 
Farncombe Family Digestive Health Research Institute, McMaster University;
Consultant Gastroenterologist, Division of Gastroenterology, Hamilton Health Sciences,
Hamilton, Ontario, Canada

Dr. David Armstrong is Professor of Medicine at McMaster University. His research interests include gastroesophageal reflux disease (GERD), dyspepsia, gastrointestinal (GI) motility, nutrition, short bowel syndrome, colon cancer screening and quality in endoscopy with over 190 peer-reviewed publications, 100 invited reviews and letters and 300 peer-reviewed abstracts. He has been a principal investigator for numerous clinical trials and taken part in many guideline consensus processes related to GERD, Helicobacter pylori, dysphagia, upper GI bleeding, gastroparesis, wireless capsule endoscopy and endoscopy quality. He is Past-President of the Canadian Association of Gastroenterology (CAG), Chair of the Canadian National Colon Cancer Screening Network (NCCSN), Treasurer of the International Working Group on the Classification of Oesophagitis (IWGCO), Vice-Chair of the Guidelines Committee for the World Gastroenterology Organization (WGO) and a Board Member of the Canadian Digestive Health Foundation (CDHF) since 2008.

Presentation Overview:
The treatment of acid-related disorders advanced, remarkably, over the last 4 decades following the development of effective acid-suppression agents in the form of histamine H2-receptor antagonists and proton pump inhibitors (PPIs) and the identification of Helicobacter pylori and non-steroidal anti-inflammatory drugs (NSAIDs) as the cause peptic ulcer disease in most patients. However, PPI therapy does not produce healing or symptom relief in all patients with apparent acid-related disorders, leading to the development of new compounds to enhance acid suppression. Conversely, there have been concerns, throughout, that potent acid suppression may be overused and their use may be associated with harms, including the development of gastrointestinal malignancy and many other conditions, ranging from enteric infections, to skeletal fractures and dementia. Presentations at DDW 2019 have addressed the topics of persistent GERD despite PPI therapy, the treatment of H. pylori negative peptic ulcer, PPI prophylaxis for patients taking aspirin or anticoagulants, potential harms from PPI therapy and the role of other acid suppressant agents. 

11:40 am - 12:00 pm Therapeutic Endoscopy
Room:  Crown
Speaker: Dr. Mohammad Yaghoobi †
 denotes real or potential conflict of interest

 

Details

Mohammad Yaghoobi, MD, MSc. (Epi), AFS, FRCP(C), FACG
Therapeutic Endoscopist, Assistant Professor of Medicine
Division of Gastroenterology, McMaster University

Dr. Mohammad Yaghoobi received his medical degree from Tehran University School of Medicine followed by a master’s degree in health research methodology at McMaster University, residency in internal medicine at University of Toronto, clinical GI fellowship at McGill University and advanced endoscopy training at Medical University of South Carolina.

He holds various editorial and research positions including editor of Cochrane Upper Gastrointestinal and Pancreatic Diseases, associate editor of the Journal of the Canadian Association of Gastroenterology (JCAG), former Editor-in-Chief of the ACG Case Reports Journal, member of the ACG educational affairs committee and the co-director of the GI health technology assessment group at the Farncombe Family Digestive Health Research Institute.

His clinical and research interest in therapeutic endoscopy is focused on complex polyp removal, EUS, ERCP and use of artificial intelligence in endoscopy. He also has extensive expertise in evidence-based medicine and specifically in conventional meta-analysis, meta-analysis of diagnostic test accuracy and health technology assessment.

Presentation Overview:
Dr. Yaghoobi will review the latest studies presented at the American College Of Gastroenterology Annual Conference 2018 and Digestive Disease Week 2019 on topics related to therapeutic and advanced endoscopy including EMR, ESD, EUS, ERCP, artificial intelligence and health technology assessment.

12:00 pm - 12:25 pm MORNING DISCUSSION – PART II
Room:  Crown
Moderator: Dr. James Saperia

 

Details

James Saperia, MD, FRCP(C)

Dr. Jamie Saperia completed his Internal Medicine at Queen’s University and is working towards finishing his Gastroenterology training at the University of Toronto. He will be pursuing additional training in Therapeutic Endoscopy next year.

12:25 pm - 1:25 pm Lunch
Room:  Princess
1:25 pm - 1:45 pm Non-Viral Liver Disease
Room:  Crown
Speaker: Dr. Marco Puglia †
 denotes real or potential conflict of interest

 

Details

Marco Puglia, MD, FRCP(C) 
Associate Professor
Department of Medicine, Division of Gastroenterology
McMaster University

Dr. Marco Puglia is a Gastroenterologist and Hepatologist at McMaster University. He graduated from medical school at the University of Ottawa.  He completed Internal Medicine and Gastroenterology training at McMaster University. He then completed a fellowship in Liver Transplant at the University of Toronto.  He has a general Gastroenterology and Hepatology practice with a particular interest in the management of viral hepatitis, fatty liver disease, hepatocellular carcinoma and the pre- and post-liver transplant patient. His academic interests include teaching, where he currently holds the position of Director of Medical Foundations 2 of the undergraduate medical education programme at McMaster.  In addition, Marco is involved in clinical research and he is the Principal Investigator in several clinical trials in areas such as NASH, HCV and PSC. 

Presentation Overview:
Collectively, non-viral liver diseases are the most common liver conditions, both in Canada and globally. They represent a huge health care burden both currently, and for the foreseeable future.  The majority of patients with non-viral liver disease have Non-Alcohol Fatty Liver Disease (NAFLD)/ Non-Alcohol Steatohepatitis (NASH).  Despite how common this condition is, currently, there are no approved pharmacotherapies.   However, many clinical trials are currently underway and have the potential to change the landscape of how NASH is managed.  Some of the newest data with respect to management of NASH will be presented.  In addition, there is active research ongoing in other non-viral liver diseases such as Primary Sclerosing Cholangitis and Primary Biliary Cholangitis and some of the newest data will be also be presented.

1:45 pm - 2:05 pm Viral Liver Disease
Room:  Crown
Speaker: Dr. David Wong †
 denotes real or potential conflict of interest

 

Details

David Wong, MD, FRCP(C)
Hepatologist
University Health Network and St Michael’s Hospital, Toronto

Dr. David Wong is a Hepatologist at the University Health Network and St Michael’s Hospital in Toronto. He received training in Internal Medicine at the University of Toronto, Gastroenterology at McMaster, and a PostDoctoral Fellowship at Harvard, investigating the role of T cell immune responses to hepatitis C. He is a Clinician Teacher and teaches liver disease in Toronto and Ethiopia.  His has clinics in General Hepatology, Urgent and Complex Care, and Liver disease in those living with HIV.  His interests in Hepatology include hepatitis B, hepatitis C, and alcohol related liver disease. Dr. Wong has won numerous teaching awards. In 2019, he was inducted into the University of Toronto’s Academy of Master Clinicians for excellence in clinical care. 

2:05 pm - 2:25 pm Surgical Abstracts
Room:  Crown
Speaker: Dr. Cagla Eskicioglu †
 denotes real or potential conflict of interest

 

Details

Cagla Eskicioglu, MD, MSc, FRCS(C) 
Associate Professor, General Surgery/Colorectal
McMaster University, Hamilton, ON
St. Joseph's Healthcare
Hamilton, ON

Dr. Eskicioglu is an Associate Professor in the Department of Surgery at McMaster University, specializing in Colorectal Surgery.

Dr. Eskicioglu received her MD from the University of Toronto in 2005 and completed her residency training in General Surgery at the University of Toronto in 2011. She got her Masters of Clinical Epidemiology at the University of Toronto. Before her current position as a General Surgeon at St. Joseph’s Healthcare Hamilton, she completed a Colorectal Surgery Clinical fellowship at Lahey Clinic, Boston, MA in 2013.

2:25 pm - 2:50 pm AFTERNOON DISCUSSION – PART I
Room:  Crown
Moderator: Dr. Nicky Marwaha

 

Details

Avantika (Nicky) Marwaha, MD, FRCP(C)
GI Health Centre

Dr. Avantika Marwaha grew up in Montreal during her formative years and learned to speak French at a very early age. She continued her high school and University studies in French. She is therefore fluently bilingual in both of Canada’s national languages. She is also fluent in Hindi, Punjabi and Urdu.

Dr. Marwaha completed a Bachelor’s of Science degree in Occupational Therapy at the University of Ottawa in 2000. She graduated with high distinction and was a Silver Medallist in the graduating class. She then enrolled in the bilingual medical school at the University of Ottawa and graduated with distinction in 2004.

Dr. Marwaha completed her internal medicine and gastroenterology training at McMaster University. She graduated from the Gastroenterology program in 2010. During her training, she worked on research related to the prevalence and risk factors for dyspepsia with Dr. Paul Moayyedi, an internationally renowned gastroenterologist. She did an oral presentation related to this topic at the Digestive Disease Week (DDW) 2009 conference, an important International conference for gastroenterologists.

She also trained under the auspices of Dr. Richard Hunt and Dr. Stephen Collins, two very prominent and award winning gastroenterologists known worldwide for their advancement and research contributions to the field of gastroenterology.

Dr. Marwaha is passionate about working in underserviced areas and with underprivileged communities. She has provided internal medicine and gastroenterology care to many underserviced areas within Canada, including Thunder Bay, Ontario; Yellowknife, Northwest Territories and Cambridge Bay, Nunavut. She also did an educational elective at the All India Institute of Medical Sciences (AIIMS), a government hospital in New Delhi, India, during her gastroenterology training. These experiences have instilled in her the importance of providing holistic and culturally-sensitive care to patients.

Dr. Marwaha keeps abreast of recent advances in gastroenterology through participation in monthly journal clubs, attendance at International conferences and through personal readings. During her free time, she enjoys traveling, reading, cooking and spending time with loved ones.

Dr. Marwaha is very keen to bring her knowledge and skills to the GI Health Centre, providing vital GI-related services to Burlington and to the surrounding communities.

2:30 pm - 3:30 pm Working Coffee Break
Room:  Back of Crown
2:50 pm - 3:10 pm Endoscopic Quality
Room:  Crown
Speaker: Dr. David Morgan †
 denotes real or potential conflict of interest

 

Details

David Morgan, MD, MSc., FRCP(C) 
Vice President, OAG
Head, Service of Gastroenterology
St. Joseph's Healthcare, Hamilton
Associate Professor, Division of Gastroenterology
McMaster University

Dr. David Morgan completed his undergraduate training in Human Genetics at McGill University. He did graduate studies including a Masters in Population Genetics. His undergraduate medical studies were completed at McMaster University and Post Graduate studies including Internal Medicine and Gastroenterology, were also completed at McMaster. Dr. Morgan took an additional fellowship year with special attention paid to advanced endoscopic techniques including YAG laser.

Dr. Morgan has published on topics such as GI Bleeding, Quality of Life in Cancer Care, Use of Proton Pump Inhibitors and The Prevention of Bleeding from GI Vascular Lesions. Dr. Morgan has participated on several CAG Consensus Panels dealing with such topics as CRC Screening. Dr. Morgan is a member of several international societies, is a Past President of the Canadian Association of Gastroenterology and is the current Vice President of the Ontario Association of Gastroenterology. Dr. Morgan is an Associate Editor for the ACP Journal Club and Evidence Based Medicine and has acted as a reviewer for many journals.

Dr. Morgan is on the Faculty at McMaster University and is involved in teaching at the undergraduate and post-graduate levels. He serves on many university and hospital committees. Dr. Morgan is Head of the Service of Gastroenterology and Deputy Chief of Medicine at St. Joseph's Hospital, Hamilton.

3:10 pm - 3:30 pm Top Four Clinical Abstracts
Room:  Crown
Speaker: Dr. Anne Hu

 

Details

Anne Hu, MD, FRCP(C) 
PGY5 Resident, Division of Gastroenterology
McMaster University 

Dr. Anne Hu is a PGY5 gastroenterology resident at McMaster University. She also completed her medical training in internal medicine at McMaster. She will be pursuing an advanced IBD fellowship at MGH in Boston starting July 2019. 

Presentation Overview:
There were several excellent abstracts from Digestive Diseases Week in San Diego this year. This talk will review four clinical abstracts. 

3:30 pm - 3:55 pm AFTERNOON DISCUSSION – PART II
Room:  Crown
Moderator: Dr. Michael Gould

 

Details

Michael Gould, MD, FRCP(C)
Assistant Professor, University of Toronto
President and Medical Director, Vaughan Endoscopy Clinic
Past President, Ontario Association of Gastroenterology

Dr. Michael Gould is the President and Medical Director of the Vaughan Endoscopy Clinic. He is Vice President and a partner in the Toronto Digestive Disease Associates (TDDA) clinical research group, which has participated in many GI clinical research trials. He is the interim Endoscopy Director at William Osler Health System.

Dr. Gould is a former Chief of Medicine of the William Osler Health System. He is a Past President and a founding member of the Ontario Association of Gastroenterology, and currently sits on the its Board of Directors. He is a board member of the Israel Cancer Research Fund. He was the CCO Endoscopy Lead from 2011- 2014, and helped design the Endoscopy QBP.

He has been a member of numerous colon screening guideline and quality committees at both the provincial and national levels.

3:55 pm - 4:00 pm Closing Remarks
Room:  Crown
Speaker: Dr. Michael Gould

 

Details

Michael Gould, MD, FRCP(C)
Assistant Professor, University of Toronto
President and Medical Director, Vaughan Endoscopy Clinic
Past President, Ontario Association of Gastroenterology

Dr. Michael Gould is the President and Medical Director of the Vaughan Endoscopy Clinic. He is Vice President and a partner in the Toronto Digestive Disease Associates (TDDA) clinical research group, which has participated in many GI clinical research trials. He is the interim Endoscopy Director at William Osler Health System.

Dr. Gould is a former Chief of Medicine of the William Osler Health System. He is a Past President and a founding member of the Ontario Association of Gastroenterology, and currently sits on the its Board of Directors. He is a board member of the Israel Cancer Research Fund. He was the CCO Endoscopy Lead from 2011- 2014, and helped design the Endoscopy QBP.

He has been a member of numerous colon screening guideline and quality committees at both the provincial and national levels.

 


© 2019 Ontario Association of Gastroenterology
^